Mundipharma is continuing to grow and is now working on the commercialisation of innovative products to manage pain and treat asthma, rheumatoid arthritis and non-Hodgkin’s lymphoma
Related Posts:
Mundipharma is continuing to grow and is now working on the commercialisation of innovative products to manage pain and treat asthma, rheumatoid arthritis and non-Hodgkin’s lymphoma
November 30, 2016
Mundipharma, an international pharmaceutical leader in pain management, recently hosted the third Cancer Care Summit in Morocco on Oct. 21-22.
Read more →
Sign-up for the Weekly Newsletter from Gulf News Journal.